Gapping down
In reaction to earnings/guidance:
- STIM -23.4% (lowers Q3 guidance, issues downside FY21 guidance), VOXX -6.8%, CTSO -4.2% (issues downside Q3 revenue guidance; also receives full FDA IDE approval to begin US STAR-D trial)
Other news:
- SRPT -6.4% (announces $500 mln stock offering; also provides Q3 product revenue guidance)
- NAPA -6.2% (stock offering)
- CRSP -6% (announces positive results from Phase 1 CARBON Trial of CTX110)
- EFC -3.9% (prices offering of 5 mln shares of common stock for gross proceeds of $91.3 mln)
- WFG -3.2% (to acquire Angelina Forest Products lumber mill for $300 mln)
- SWKS -2.6% (Apple reportedly to cut production on iPhone production targets)
- SYBX -2.5% (announces publication of preclinical research demonstrating novel application of Synthetic Biotic platform)
- RNR -2.2% (estimates Q3 catastrophic losses at $725 mln)
- CME -2.1% (reports monthly ADV)
- SBRA -2% (prices offering 6.8 mln shares of common stock for gross proceeds of $98.9 mln)
- PYCR -2% (stock offering)
- SNCY -1.9% (stock offering)
- QRVO -1.1% (Apple reportedly to cut production on iPhone production targets)
- CRUS -1% (Apple reportedly to cut production on iPhone production targets)
- AVGO -0.9% (Apple reportedly to cut production on iPhone production targets)
Analyst comments:
- BRBR -1.4% (downgraded to Hold from Buy at Truist)